Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Malik Shahzad

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ITRMIterum Therapeutics plcMalik ShahzadDirectorMay 30, 2018Buy$13.00228,8402,974,920838,325May 30, 2018, 05:29 PM
ITRMIterum Therapeutics plcMalik ShahzadDirectorMay 30, 2018Buy$13.008,144105,87229,836May 30, 2018, 05:29 PM
VSARVersartis, Inc.Malik ShahzadDirectorMar 17, 2017Sale$18.01386,3676,958,4701,621,558Mar 17, 2017, 05:29 PM
VSARVersartis, Inc.Malik ShahzadDirectorMar 16, 2017Sale$18.5097,3031,800,1062,007,925Mar 17, 2017, 05:29 PM
VSARVersartis, Inc.Malik ShahzadDirectorMar 13, 2017Sale$19.4216,330317,1292,255,228Mar 15, 2017, 05:44 PM
VSARVersartis, Inc.Malik ShahzadDirectorMar 14, 2017Sale$19.0046,878890,6852,255,128Mar 15, 2017, 05:44 PM
VSARVersartis, Inc.Malik ShahzadDirectorMar 15, 2017Sale$19.08103,1221,967,5682,105,228Mar 15, 2017, 05:44 PM
AGENAGENUS INCMalik ShahzadDirectorMay 27, 2015Option Exercise$6.301,587,30210,000,0031,587,302May 27, 2015, 04:50 PM
AGENAGENUS INCMalik ShahzadDirectorMay 08, 2014Option Exercise$3.00111,289333,7561,107,377Apr 30, 2015, 08:59 PM
AGENAGENUS INCMalik ShahzadDirectorApr 28, 2015Sale$7.16700,0005,012,560407,377Apr 30, 2015, 08:59 PM
AGENAGENUS INCMalik ShahzadDirectorApr 29, 2015Sale$7.02407,3772,858,8090Apr 30, 2015, 08:59 PM
VSARVersartis, Inc.Malik ShahzadDirectorJan 22, 2015Buy$17.2555,000948,7502,271,558Jan 26, 2015, 05:13 PM
VSARVersartis, Inc.Malik ShahzadDirectorMar 26, 2014Buy$21.0060,0001,260,0002,216,558Mar 27, 2014, 05:12 PM
CNATConatus Pharmaceuticals IncMalik ShahzadDirectorJul 30, 2013Option Exercise$8.27279,8152,313,7072,166,836Aug 01, 2013, 07:14 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe